CN Stock MarketDetailed Quotes

002275 Guilin Sanjin Pharmaceutical

Watchlist
  • 15.09
  • +0.33+2.24%
Market Closed Dec 20 15:00 CST
8.87BMarket Cap21.71P/E (TTM)

Guilin Sanjin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guilin Sanjin Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
506.37M
--
+15.71%
EPS
--
0.14
--
--
Analyst Rating
Strong Buy

Dec 21, 2024

Guilin Sanjin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.481B--
--2024/FY-- / 2.246B--
--2023/FY2.172B / 2.296B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.481B--
--2024/FY-- / 2.246B--
--2023/FY2.172B / 2.296B--
--------
--------

Unlock Free Earnings Estimates

Guilin Sanjin Pharmaceutical Earnings Reports

  • Guilin Sanjin: Report for the third quarter of 2024

    Oct 29 12:00 ET

  • Guilin Sanjin: Semi-Annual Report 2024

    Aug 28 12:00 ET

  • Guilin Sanjin: 2024 Semi-Annual Report Summary

    Aug 28 12:00 ET

  • Guilin Sanjin Pharmaceutical: 2024 FIRST QUARTER REPORT (CORRECTED)

    Apr 26 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Strong Buy

    • Strong Buy

      57.14%

    • Buy

      42.86%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Traditional Chinese Medicine Concept
    Traditional Chinese Medicine Concept
    Intraday+0.82%
    Health China
    Health China
    Intraday+0.56%